unknown
Stage
About
Beren Therapeutics is a public benefit corporation focused on developing transformative medicines for rare diseases, including investigational drugs like Adrabetadex for Infantile-Onset Niemann-Pick Disease, Type C.
Explore Beren Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.